Moneycontrol
Get App
you are here: HomeNewsBusiness
Last Updated : Feb 10, 2020 05:58 PM IST | Source: Moneycontrol.com

Reporter’s Take | Coronavirus outbreak can severely damage India’s pharma industry

Moneycontrol’s Shraddha Sharma talks to Viswanath Pilla on how the disruption in drug supply due to nCoV is affecting India’s pharma industry.


Over 900 people have died in China following the novel coronavirus outbreak, which has now spread to at least 25 countries. Although efforts are being made to contain the virus, a negative impact is being witnessed on the pharma sector in India.

The country imports large quantities of active pharmaceutical ingredients (APIs) from neighbouring China and if the situation does not improve, it will severely impact the supply of APIs.

In this episode of Reporter’s Take, Moneycontrol’s Shraddha Sharma talks to Viswanath Pilla on how the disruption in drug supply due to nCoV is affecting India’s pharma industry.

Close
Watch the video for more.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Feb 10, 2020 05:58 pm
Sections
Follow us on